Barclays’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $665K | Buy |
|
|||||
|
2025
Q1 | $402K | Sell |
|
|||||
|
2024
Q4 | $370K | Buy |
|
|||||
|
2024
Q3 | $434K | Buy |
|
|||||
|
2024
Q2 | $590K | Buy |
|
|||||
|
2024
Q1 | $378K | Sell |
|
|||||
|
2023
Q4 | $303K | Buy |
|
|||||
|
2023
Q3 | $56K | Sell |
|
|||||
|
2023
Q2 | $65K | Sell |
|
|||||
|
2023
Q1 | $149K | Buy |
|
|||||
|
2022
Q4 | $187K | Sell |
|
|||||
|
2022
Q3 | $1.8M | Buy |
|
|||||
|
2022
Q2 | $385K | Sell |
|
|||||
|
2022
Q1 | $797K | Sell |
|
|||||
|
2021
Q4 | $1.29M | Buy |
|
|||||
|
2021
Q3 | $921K | Buy |
|
|||||
|
2021
Q2 | $666K | Sell |
|
|||||
|
2021
Q1 | $2.25M | Buy |
|
|||||
|
2020
Q4 | $1.44M | Sell |
|
|||||
|
2020
Q3 | $1.06M | Buy |
|
|||||
|
2020
Q2 | $1.01M | Buy |
|
|||||
|
2020
Q1 | $511K | Sell |
|
|||||
|
2019
Q4 | $2.07M | Sell |
|
|||||
|
2019
Q3 | $1.75M | Buy |
|
|||||
|
2019
Q2 | $924K | Buy |
|
|||||
|
2019
Q1 | $945K | Buy |
|
|||||
|
2018
Q4 | $674K | Sell |
|
|||||
|
2018
Q3 | $1.95M | Buy |
|
|||||
|
2018
Q2 | $320K | Sell |
|
|||||
|
2018
Q1 | $839K | Buy |
|
|||||
|
2017
Q4 | $210K | Sell |
|
|||||
|
2017
Q3 | $465K | Buy |
|
|||||
|
2017
Q2 | $74K | Buy |
|
|||||
|
2017
Q1 | $29K | Sell |
|
|||||
|
2016
Q4 | $162K | Buy |
|
|||||
|
2016
Q3 | $10K | Sell |
|
|||||
|
2016
Q2 | $558K | Buy |
|
|||||
|
2016
Q1 | $157K | Buy |
|
|||||
|
2015
Q4 | $127K | Buy |
|
|||||
|
2015
Q3 | $9K | Sell |
|
|||||
|
2015
Q2 | $17K | Sell |
|
|||||
|
2015
Q1 | $11K | Sell |
|
|||||
|
2014
Q4 | $19K | Buy |
|
|||||
|
2014
Q3 | $6K | Sell |
|
|||||
|
2014
Q2 | $11K | Buy |
|